• SENSEX 73,246.03
    -352.64 (--0.48%)
  • BANKNIFTY 54,267.40
    292.50 (+0.54%)
  • Jio Platforms
    1,423.80 1,423.80(%)
  • NSE
    1,766.00 1,640.25(%)
  • Reliance Industries
    1,156.60 1,152.30(%)
  • Piramal Pharma
    235.45 235.45(%)
  • United Breweries
    1,316.00 1,845.90(%)
  • Larsen & Toubro
    3,892.00 4,440.00(%)
  • Billionbrains
    190.80 227.00(%)
  • Swiggy
    183.05 174.30(%)
  • Cholaman.Inv.&Fn
    1,557.55 1,952.00(%)
  • Syngene Intl.
    418.75 678.00(%)
  • HDFC Bank
    687.15 1,017.90(%)
  • Lenskart Solut.
    697.50 725.00(%)
  • HDFC AMC
    2,317.50 2,901.00(%)
  • Patanjali Foods
    375.20 613.95(%)
  • Ola Electric
    37.44 51.84(%)
  • One 97
    1,640.50 1,856.50(%)
  • Acutaas Chemical
    3,686.00 1,571.20(%)
  • Sahajanand Medi
    462.10 347.50(%)
  • Jubilant Ingrev.
    581.55 535.30(%)
  • FSN E-Commerce
    345.45 351.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Anthem Biosciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 33976.0
  • ISIN : INE0CZ201020
832.15 -5 (-0.60%)
  • As on 28 Oct 2026 (EOD)

  • Today’s Low

    827.05

  • Today’s High

    836.55

  • Open

    834.00

  • Perv Close

    837.15

  • 52W Low

    579.15

  • 52W High

    977.55

Key Indicators

  • P/E(TTM)

    72.97

  • Mar.Cap (₹Cr.)

    46,878.20

  • Div & Yield %

    0.24

  • Book Value(₹)

    56.54

  • Debt-Equity Ratio

    -0.60

  • AGM Date

    28-Oct-2026

  • EPS

    11.40

  • P/E Ratio

    72.97

Financials Ratios

  • Debt-Equity Ratio

    0.10

  • Mar.Cap (₹Cr.)

    46,878.20

  • RONW (%)

    20.04

  • ROCE (%)

    23.98

Score Board

  • Equity (₹ in Cr.)

    112.67

  • BV (₹)

    56.50

  • Sales( ₹ in Cr.)

    2,089.31

  • NP (in Cr.)

    686.46

  • NP Var(%)

    36.0

  • Div%

    100.0

  • CPS (₹)

    14.00

  • EPS (₹)

    12.20

  • Traded Value (₹ in Lakhs)

    46,861.30

  • 52 Week High

    977.55

  • 52 Week Low

    579.15

  • Price BSE

    832.0

  • Price NSE

    832.00

  • Market Capital( in Cr.)

    46,861.30

  • P/C Ratio

    59.60

  • P/E Ratio

    68.30

  • Price Vs.BV

    12.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 2,089.31 1,840.65 1,417.54 1,056.92 1,231.26 1,103.24
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 2,089.31 1,840.65 1,417.54 1,056.92 1,231.26 1,103.24
Other Income 182.08 109.44 70.52 139.17 48.98 37.21
Stock Adjustments -98.69 86.71 41.23 9.01 1.37 -39.12
Total Income 2,172.70 2,036.80 1,529.29 1,205.10 1,281.61 1,101.33
EXPENDITURE :            
Raw Materials 696.75 828.08 640.77 348.29 410.30 407.88
Power and Fuel Cost 52.13 42.56 31.29 38.95 36.32 34.23
Employee Cost 262.46 251.76 182.65 153.24 137.51 142.19
Other Manufacturing Expenses 48.29 46.27 34.13 21.11 23.38 22.76
Selling and Administration Expenses 56.60 56.41 54.67 60.66 48.21 33.66
Miscellaneous Expenses 47.12 13.08 10.25 12.68 11.46 15.67
Employee Benefit Expenses 262.46 251.76 182.65 153.24 137.51 142.19
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,163.35 1,238.15 953.77 634.92 667.18 656.38
Operating Profit 1,009.35 798.65 575.52 570.19 614.44 444.95
Interest 6.71 9.29 9.26 8.71 10.09 16.97
Gross Profit 1,002.64 789.36 566.26 561.48 604.35 427.98
Depreciation 99.57 77.94 81.49 63.70 57.76 62.40
Profit Before Tax 903.07 711.42 484.77 497.78 546.59 365.58
Current Tax 241.31 182.03 126.41 120.05 142.39 96.70
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -8.80 23.21 -16.42 -7.94 -1.79 -2.43
Reported Net Profit 670.56 506.19 374.78 385.67 405.99 271.31
Extraordinary Items -15.90 -0.26 -0.21 40.84 -0.14 -0.14
Adjusted Net Profit 686.46 506.45 374.99 344.83 406.13 271.45
Adjustment below Net Profit -67.06 -50.62 -71.60 -139.35 0.00 0.00
P & L Balance brought forward 1,979.72 1,524.15 1,220.97 974.65 568.66 362.71
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 26.08
P & L Balance carried down 2,583.23 1,979.72 1,524.15 1,220.97 974.65 607.93
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 100.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 2.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 11.94 9.05 6.70 6.76 462.60 319.76
Earnings Per Share(Adj)-Unit Curr 11.94 - - - - -
Book Value 56.70 44.24 34.58 30.53 1,544.46 826.76
Book Value(Adj)-Unit Curr 56.70 - - - - -

Shareholding Pattern

  • Promoter Group

    71.40%

  • Public Share Holding

    28.60%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 390,940,039 69.37 390,940,039 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 11,409,736 2.02 11,409,736 2
Others 0 0.00 0 0
Sub Total 402,349,775 71.40 402,349,775 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 21,373,877 3.79 21,373,877 117
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 9,678,772 1.72 9,678,772 8
Mutual Funds / UTI 52,138,271 9.25 52,138,271 31
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 6,393,127 1.13 6,393,127 15
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 89,584,047 15.90 89,584,047 171
2] Non Institution
Bodies Corporate 2,072,304 0.37 2,072,304 374
Clearing Members 2,000 0.00 2,000 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 216,856 0.04 216,856 1,383
Foreign Non Institution Other 15,396,327 2.73 15,396,327 1
Hindu Undivided Families 495,884 0.09 495,884 5,100
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 43,052,780 7.64 43,052,780 5
Individuals holding nominal share capital up to Rs. 1 lakh 10,300,571 1.83 10,300,571 169,164
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1 0.00 1 1
Others 57,500 0.01 57,500 2
Sub Total 71,594,223 12.70 71,594,223 176,031
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 563,528,045 100.00 563,528,045 176,209

Company Background

Anthem Biosciences LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Anthem Biosciences Ltd
  • BSE Code : 33976.0
  • ISIN : INE0CZ201020

  • Incorporation Year

    2006

  • Registered Office

    49 F1 & F2 Canara Bank Road
    Bommasandra Industrial Area, Bangalore,
    Karnataka-560099

  • Telephone

    +91 080 6672 4000

  • FAX

  • Chairman

    Ajay Bhardwaj

  • Managing Director

    Ajay Bhardwaj

  • Company Secretary

    Divya Prasad

  • Auditor

    K P Rao & Co/S R Batliboi & Associates LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Anthem Biosciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Anthem Bioscienc 831.85 2,271.39 2,089.31 75.08 30.98
Abbott India 26,278.90 7,217.19 6,929.05 34.58 43.78
Astrazeneca Phar 6,234.70 2,304.07 2,275.58 91.89 27.86
Glaxosmi. Pharma 2,496.65 3,932.76 3,790.20 39.88 58.17
Novartis India 1,805.95 393.10 354.33 45.60 15.94
Cipla 1,360.00 20,102.60 18,979.95 41.45 13.88
Bliss GVS Pharma 650.05 773.53 729.81 60.41 12.51
Amrutanjan Healt 491.10 520.13 502.55 26.30 24.16
Fermenta Biotec. 443.85 474.15 450.25 20.72 18.77
Guj. Themis Bio. 355.25 168.25 165.82 94.99 18.05
Ambalal Sarabhai 35.73 19.52 3.94 66.17 6.77